Format

Send to

Choose Destination
AJR Am J Roentgenol. 2008 May;190(5):W290-3. doi: 10.2214/AJR.07.3198.

MRI of hepatic adenomatosis: initial observations with gadoxetic acid contrast agent in three patients.

Author information

1
Department of Radiology, University Hospital Basel, Basel, Switzerland. olivier.giovanoli@ksa.ch

Abstract

OBJECTIVE:

The purpose of our study was to describe the MR signal characteristics of histologically proven liver adenomatosis in three patients using gadoxetic acid, a newly developed liver-specific MR contrast agent.

CONCLUSION:

In all three patients, more than 100 liver adenomas revealed no metabolism of the new liver-specific contrast agent in the delayed phase. Because of absent or strongly reduced intracellular uptake of gadoxetic acid in all adenomas during delayed contrast-enhanced series, differentiation of adenomas from dysplastic or malignant lesions was not possible.

PMID:
18430814
DOI:
10.2214/AJR.07.3198
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center